Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes.

Richeek PradhanHui YinOriana H Y YuLaurent Azoulay

Published in: Diabetes care (2022)

In this population-based study, DPP-4 inhibitors were associated with an increased risk of acute liver injury compared with SGLT-2 inhibitors in patients with type 2 diabetes. In contrast, an increased risk of acute liver injury was observed only among female GLP-1 RA users.

Keyphrases

drug induced
liver injury
liver failure
magnetic resonance
intensive care unit
computed tomography
systemic lupus erythematosus
hepatitis b virus
systemic sclerosis
aortic dissection